Radiopharm Theranostics Limited (AU:RAD) has released an update.
Radiopharm Theranostics Limited has announced the application for quotation of a significant number of securities on the ASX, with an issue date of September 13, 2024. The application includes 93,750,000 ordinary fully paid shares and 46,875,000 options expiring in August 2026. This move indicates a potential expansion and investment opportunity for stakeholders in the pharmaceutical sector.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.
